KonishiKONISHI CO.,LTD.4956東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

Konishi revenue and profit

Out of every ¥100 of sales, about ¥8 is left as operating profit. Revenue changed +0.6% from the prior year, operating profit -0.9%.

Five-year trend

Revenue¥136.6B
FY ending Mar 2022: ¥113.7B¥113.7BFY ending Mar 2023: ¥123.3B¥123.3BFY ending Mar 2024: ¥133B¥133BFY ending Mar 2025: ¥135.7B¥135.7BFY ending Mar 2026: ¥136.6B¥136.6BFY22FY23FY24FY25FY26
Operating income¥10.5B
FY ending Mar 2022: ¥7.3B¥7.3BFY ending Mar 2023: ¥7.42B¥7.42BFY ending Mar 2024: ¥10.3B¥10.3BFY ending Mar 2025: ¥10.6B¥10.6BFY ending Mar 2026: ¥10.5B¥10.5BFY22FY23FY24FY25FY26
Operating margin7.7%
FY ending Mar 2022: 6.4%6.4%FY ending Mar 2023: 6.0%6.0%FY ending Mar 2024: 7.7%7.7%FY ending Mar 2025: 7.8%7.8%FY ending Mar 2026: 7.7%7.7%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin5.9%
Asset turnover0.99×
ROA5.8%
ROA5.8%
Financial leverage1.74×
ROE10.1%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin5.9%
2022: 4.5%4.5%2023: 8.1%8.1%2024: 5.5%5.5%2025: 6.0%6.0%2026: 5.9%5.9%2223242526
Asset turnover0.99×
2022: 0.95×0.95×2023: 0.98×0.98×2024: 0.97×0.97×2025: 0.98×0.98×2026: 0.99×0.99×2223242526
ROA5.8%
2022: 4.3%4.3%2023: 8.0%8.0%2024: 5.4%5.4%2025: 5.8%5.8%2026: 5.8%5.8%2223242526
Financial leverage1.74×
2022: 1.84×1.84×2023: 1.83×1.83×2024: 1.90×1.90×2025: 1.84×1.84×2026: 1.74×1.74×2223242526
ROE10.1%
2022: 7.9%7.9%2023: 14.6%14.6%2024: 10.2%10.2%2025: 10.7%10.7%2026: 10.1%10.1%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20224.5%0.95×4.3%1.84×7.9%
20238.1%0.98×8.0%1.83×14.6%
20245.5%0.97×5.4%1.90×10.2%
20256.0%0.98×5.8%1.84×10.7%
20265.9%0.99×5.8%1.74×10.1%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue23.8%
2021: 24.0%24.0%2022: 22.5%22.5%2023: 20.9%20.9%2024: 22.3%22.3%2025: 24.1%24.1%2026: 23.8%23.8%212223242526
PPE ÷ total assets23.3%
2021: 22.7%22.7%2022: 21.5%21.5%2023: 19.4%19.4%2024: 21.1%21.1%2025: 23.9%23.9%2026: 23.3%23.3%212223242526
Goodwill ÷ parent equity0.3%
2021: 0.7%0.7%2022: 0.3%0.3%2023: 0.7%0.7%2024: 0.6%0.6%2025: 0.3%0.3%2026: 0.3%0.3%212223242526
Goodwill balance¥205M
2021: ¥399M¥399M2022: ¥183M¥183M2023: ¥523M¥523M2024: ¥399M¥399M2025: ¥273M¥273M2026: ¥205M¥205M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥1.69B
2021: ¥1.66B¥1.66B2022: ¥1.61B¥1.61B2023: ¥1.65B¥1.65B2024: ¥1.64B¥1.64B2025: ¥1.65B¥1.65B2026: ¥1.69B¥1.69B212223242526
R&D / revenue1.2%
2021: 1.5%1.5%2022: 1.4%1.4%2023: 1.3%1.3%2024: 1.2%1.2%2025: 1.2%1.2%2026: 1.2%1.2%212223242526
Receivable days—
2021: 131d131d212223242526
Payable days110d
2021: 126d126d2022: 128d128d2023: 124d124d2024: 128d128d2025: 110d110d2026: 110d110d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue113,671123,339132,969135,690136,569
Cost of revenue90,66599,756106,312108,191108,528
Gross profit23,00623,58326,65727,49828,041
SG&A15,70716,16116,37016,94317,577
Operating income7,2987,42110,28610,55510,464
Pretax income7,98015,05211,04111,50311,954
Income tax2,5734,7093,2953,3043,918
Net income attributable to owners5,13510,0327,3448,0848,033
Operating margin6.4%6.0%7.7%7.8%7.7%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 14%
Property, plant and equipment 23%
4%
8%
Other assets 51%

Funding

Trade payables 23%
Other liabilities 13%
Equity 64%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥25.5B¥31.3B¥25.6B¥20B¥19.4B
Total assets¥119.1B¥132.9B¥140.8B¥136.8B¥139.6B
Net assets¥72.9B¥81.5B¥84.7B¥86.7B¥88.9B
Share capital¥4.6B¥4.6B¥4.6B¥4.6B¥4.6B
Property, plant and equipment¥25.6B¥25.7B¥29.7B¥32.8B¥32.5B
Intangible assets excluding goodwill¥811M¥1.19B¥1.98B¥3.11B¥4.74B
Goodwill¥183M¥523M¥399M¥273M¥205M
Investment securities¥7.63B¥8.08B¥11.4B¥9.84B¥10.8B
Current assets¥82.3B¥94.4B¥92.6B¥85.8B¥83.3B
Current liabilities¥41.2B¥45.9B¥49.1B¥43.3B¥42.7B
Trade payables¥31.7B¥34B¥37.2B¥32.6B¥32.8B
Short-term borrowings¥46M¥48M¥50M¥51M¥25M
Long-term borrowings¥256M¥116M¥76M¥38M¥3M
Total liabilities¥46.3B¥51.4B¥56.2B¥50.1B¥50.8B
Non-controlling interests¥4.23B¥4.51B¥5.01B¥419M¥404M
Equity attributable to owners of parent¥64.8B¥72.7B¥71.7B¥79.1B¥79.4B
Retained earnings¥61.2B¥69.5B¥67.3B¥73B¥78.4B
Treasury stock-¥5.5B-¥5.9B-¥4.6B-¥4.51B-¥9.66B

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2025/04/01-2026/03/31)

    ID S100YC072026-06-16Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(2024/04/01-2025/03/31)

    ID S100VYCB2025-06-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(2023/04/01-2024/03/31)

    ID S100TMOP2024-06-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第98期(2022/04/01-2023/03/31)

    ID S100QZF52023-06-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第97期(令和3年4月1日-令和4年3月31日)

    ID S100OAYJ2022-06-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第96期(令和2年4月1日-令和3年3月31日)

    ID S100LLQ92021-06-22Open

Extracted from XBRL: 54 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.